Literature DB >> 12884437

Antenatal onset of cortical hyperostosis (Caffey disease): case report and review.

Susann Schweiger1, Rabih Chaoui, Cornelia Tennstedt, Katarina Lehmann, Stefan Mundlos, Sigrid Tinschert.   

Abstract

We report on a fetus of 27 weeks of gestation whose clinical, radiological, and histopathological findings are compatible with the prenatal form of Caffey disease (cortical hyperostosis). Prenatal ultrasound examination showed polyhydramnios and markedly short and angulated long bones, which had led to the incorrect diagnosis of lethal osteogenesis imperfecta. We found 43 published descriptions on the antenatal onset of cortical hyperostosis symptomatic in utero or at birth. Two groups of prenatal cortical hyperostosis (PCH) can be distinguished: (1) severe (25 reports and the fetus presented here), with onset before 35 weeks of gestation and generally associated with polyhydramnios, lung disease, prematurity, and high lethality; (2) mild (18 reports), with onset after 35 weeks of gestation and without complications. Autosomal recessive inheritance has been suggested for the prenatal form of cortical hyperostosis. However, the available evidence suggests that both dominant and recessive inheritance is possible. Moreover, dominant inheritance seems to be more common in the mild prenatal form of cortical hyperostosis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12884437     DOI: 10.1002/ajmg.a.20062

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  Radiographic overlap of recurrent Caffey disease and chronic recurrent multifocal osteomyelitis (CRMO) with considerations of molecular origins.

Authors:  Teresa Chapman; Sarah J Menashe; Benjamin H Taragin
Journal:  Pediatr Radiol       Date:  2019-12-23

2.  A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.

Authors:  Robert C Gensure; Outi Mäkitie; Catherine Barclay; Catherine Chan; Steven R Depalma; Murat Bastepe; Hilal Abuzahra; Richard Couper; Stefan Mundlos; David Sillence; Leena Ala Kokko; Jonathan G Seidman; William G Cole; Harald Jüppner
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

3.  The c.3040C > T mutation in COL1A1 is recurrent in Korean patients with infantile cortical hyperostosis (Caffey disease).

Authors:  Tae-Joon Cho; Hyuk Ju Moon; Dae-Yeon Cho; Moon Seok Park; Dong Yeon Lee; Won Joon Yoo; Chin Youb Chung; In Ho Choi
Journal:  J Hum Genet       Date:  2008-08-13       Impact factor: 3.172

4.  Infantile cortical hyperostosis and COL1A1 mutation in four generations.

Authors:  Paola Cerruti-Mainardi; Giacomo Venturi; Marianna Spunton; Elena Favaron; Michela Zignani; Sandro Provera; Bruno Dallapiccola
Journal:  Eur J Pediatr       Date:  2011-05-13       Impact factor: 3.183

5.  Birth Order and Maternal Age for Reported Cases of Severe Prenatal Cortical Hyperostosis (Caffey–Silverman Disease)

Authors:  Rolf R Engel; Raul F Cifuentes
Journal:  AJP Rep       Date:  2017-09-11

6.  Fetuin-A deficiency is associated with infantile cortical hyperostosis (Caffey disease).

Authors:  Rona Merdler-Rabinowicz; Anna Grinberg; Jeffrey M Jacobson; Ido Somekh; Christoph Klein; Atar Lev; Salama Ihsan; Adib Habib; Raz Somech; Amos J Simon
Journal:  Pediatr Res       Date:  2019-07-09       Impact factor: 3.756

7.  Molecular Characterization of Three Canine Models of Human Rare Bone Diseases: Caffey, van den Ende-Gupta, and Raine Syndromes.

Authors:  Marjo K Hytönen; Meharji Arumilli; Anu K Lappalainen; Marta Owczarek-Lipska; Vidhya Jagannathan; Sruthi Hundi; Elina Salmela; Patrick Venta; Eva Sarkiala; Tarja Jokinen; Daniela Gorgas; Juha Kere; Pekka Nieminen; Cord Drögemüller; Hannes Lohi
Journal:  PLoS Genet       Date:  2016-05-17       Impact factor: 5.917

8.  TRPV6 compound heterozygous variants result in impaired placental calcium transport and severe undermineralization and dysplasia of the fetal skeleton.

Authors:  Christine P Burren; Richard Caswell; Bruce Castle; C Ross Welch; Tom N Hilliard; Sarah F Smithson; Sian Ellard
Journal:  Am J Med Genet A       Date:  2018-08-25       Impact factor: 2.802

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.